Effective management of stable angina

Quality and Safety in Health Care

Volumn 7, Issue 2, 1998, Pages 109-116

  Petticrew, Mark ^a   Sculpher, Mark ^b   Kelland, Jo ^b   Elliott, Rachel ^c   Holdright, Diana ^d   Buxton, Martin ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b BRUNEL UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPYRIDAMOLE; NITRIC ACID DERIVATIVE;

ANGINA PECTORIS; ARTICLE; ATHERECTOMY; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; HEART INFARCTION; HUMAN; LASER ANGIOPLASTY; META ANALYSIS; QUALITY OF LIFE; STENT; STROKE; SYMPTOM; TRANSLUMINAL CORONARY ANGIOPLASTY; UNITED KINGDOM;

ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; COST-BENEFIT ANALYSIS; DISEASE MANAGEMENT; EVIDENCE-BASED MEDICINE; GREAT BRITAIN; HUMANS; STATE MEDICINE; VASODILATOR AGENTS;

EID: 0031816719     PISSN: 09638172     EISSN: None     Source Type: Journal    
DOI: 10.1136/qshc.7.2.109     Document Type: Article

References (58)

1. McCormick A, Fleming D, Charlton J. Morbidity statistics from general practice: fourth national study 1991-2. 1995: HMSO: London.
2. Ghandhi MM, Lampe FC, Wood DA. Incidence, clinical characteristics, and short-term prognosis of angina pectoris. Br Heart J 1995;73:193-8.
3. Standing Medical Advisory Committee. The use of Statins. London: Department of Health, May 1997.
4. Black N, Langham S, Petticrew M. Trends in the age and sex of patients undergoing coronary revascularisation in the United Kingdom 1987-93. Br Heart J 1994;72:317-20.
5. Black NA, Langham S, Petticrew M. Coronary revascularisation: why do rates vary geographically in the UK? J Epidemiol Community Health 1995;49:408-12.
6. Sculpher M, Petticrew M, Buxton M, et al. Resource Allocation in Chronic Stable Angina: a systematic review of the effectiveness, costs and cost-effectiveness of alternative interventions. London: Health Economics Research Group, Brunel University, 1997.
7. Management of stable angina. Effective Health Care 1997;3: 1-8.
8. Destors JM, Boisell JP, Philippon AM, et al. Controlled clinical trial of bepridil, propranolol and placebo in the treatment of exercise induced angina pectoris. Fundam Clin Pharmacol 1989;3:597-611.
9. Vliegen HW, van der Wall EE, Niemeyer MG, et al. Long-term efficacy of diltiazem controlled release versus metoprolol in patients with stable angina pectoris. J Cardiovasc Pharmacol 1991;18:S55-60.
10. Nahrendorf W, Rading A, Steinig G, et al. A comparison of carvedilol with a combination of propranolol and isosorbide dinitrate in the chronic treatment of stable angina. Cardiovasc Pharmacol 1992;19:S114-6.
11. Boberg J, Larsen FF, Pehrsson SK. The effects of β blockade with (epanolol) and without (atenolol) on intrinsic sympathomimetic activity in stable angina pectoris. Clin Cardiol 1992;15:591-5.
12. Singh S. Long term double blind evaluation of amlodipine and nadolol in patients with stable exertional angina pectoris. Clin Cardiol 1993;16:54-8.
13. Guermonprez JL, Blin P, Peterlongo F. A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris. Eur Heart J 1993;14:30-4.
14. Dargie HJ, Ford I, Fox KM. Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. Eur Heart J 1996;17:104-12.
15. Rehnqvist N, Hjemdahl P, Billin E, et al. Effects of metoprolol v verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS). Eur Heart J 1996;17:76-81.
16. Kawanishi DT, Reid CL, Morrison EC, et al. Response of angina and ischemia to long term treatment in patients with chronic stable angina: a double-blind randomised individualised dosing trial of nifedipine, propranolol and their combination. J Am Coll Cardiol 1992;19:409-17.
17. Savonitto S, Ardissiono D, Egstrup K, et al. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study. J Am Coll Cardiol 1996;27:311-6.
18. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
19. Parisi AF, Folland ED, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. N Engl J Med 1992;326:10-6.
20. RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancet 1997; 350:461-8.
21. Folland ED, Hartigan PM, Parisi AF. Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial. Veterans Affairs ACME Investigators. J Am Coll Cardiol 1997;29: 1505-11.
22. Rogers WJ, Coggin CJ, Gersh BJ, et al. Ten year follow up of quality of life in patients randomised to receive medical therapy or coronary artery bypass graft surgery. Circulation 1990; 82: 1647-58.
23. Schmuziger M, Christenson JT, Maurice J, et al. Reoperative myocardial revascularization: an analysis of 458 reoperations and 2645 single operations. Cardiovasc Surg 1994;2: 623-9.
24. Jaglal SB, Tu JV, Naylor CD. Higher in-hospital mortality in female patients following coronary artery bypass surgery: a population-based study. Provincial Adult Cardiac Care Network of Ontario. Clin Invest Med 1995;18:99-107.
25. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994;344: 563-70.
26. Pocock SJ, Henderson RA, Rickards AF, et al. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet 1995;346:1184-9.
27. Bypass Angioplasty Revascularisation Investigators (BARI). Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996;335: 217-25.
28. De Bono D. Coronary angioplasty. In: Weatherall DJ, Ledingham JG, Warrell DA, eds. Oxford textbook of medicine. Oxford: Oxford University Press, 1996:2349-53.
29. Sculpher MJ, Seed P, Henderson RA, et al. Health service costs of coronary angioplasty and coronary artery bypass surgery: the randomised intervention treatment of angina (RITA) trial. Lancet 1994;344:927-30.
30. Hillegass WB, Ohman EM, Leimberger JD, et al. A meta-analysis of randomised trials of calcium antagonists to reduce restenosis after coronary angioplasty. Am J Cardiol 1994;73:835-9.
31. Gapinski JP, VanRuiswyk JV, Heudebert GR, et al. Preventing restenosis with fish oils following coronary angioplasty. A meta-analysis. Arch Intern Med 1993;153:1595-601.
32. EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-61.
33. Topol EJ, Ferguson JJ, Weisman HF, et al. Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta 3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication. JAMA 1997;278:479-84.
34. Maresta A, Balducelli M, Cantini L, et al. Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomised double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica. Circulation 1994;90:2710-5.
35. Tardiff JC, Cote G, Lesperance J, et al. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med 1997;337:365-72.
36. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. BMJ 1994;308:159-68.
37. Azen SP, Mack WJ, Cashin-Hemphill L, et al. Progression of coronary artery disease predicts clinical coronary events. Long term follow up from the cholesterol lowering atherosclerosis study. Circulation 1996;93:34-41.
38. Mark DB, Talley JD, Topol EJ, et al. Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators. Circulation 1996;94:629-35.
39. Fischman DL, Leon MB, Baim DS, et al. A randomised comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
40. Macaya C, Serruys PW, Ruygrok P, et al. Continued benefit of coronary stenting versus balloon angioplasty: one year clinical follow up of Benestent trial. Benestent Study Group. J Am Coll Cardiol 1996;27:255-61.
41. Savoie I, Sheps S. Coronary stents: an appraisal of controlled clinical studies, Vancouver: British Columbia Office of Health Technology Assessment, 1996.
42. Sirnes PA, Golf S, Myreng Y, et al. Stenting in chronic coronary occlusion (SICCO): a randomised, controlled trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol 1996;28:1444-51.
43. Versaci F, Gaspardone A, Tomai F, et al. A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Engl J Med 1997;336:817-22.
44. Schomig A, Neumann FJ, Kastrati A, et al. et al. A randomised comparison of antiplatelet and anticoagulant therapy after coronary artery stems. N Engl J Med 1996;334:1084-9.
45. Balcon R, Beyar R, Chierchia I, et al. Recommendations on stent manufacture, implantation and utilization. Eur Heart J 1997;18:536-47.
46. Appelman YE, Piek JJ, Strikwerda S, et al. Randomised trial of excimer laser angioplasty versus balloon angioplasty for treatment of obstructive coronary artery disease. Lancet 1996;347:79-84.
47. Reifart N, Vandormael M, Krajcar M, et al. Randomized comparison of angioplasty of complex coronary lesions at a single center. Excimer laser, rotational atherectomy, and balloon angioplasty comparison (ERBAC) study. Circulation 1997;96:91-8.
48. Topol EJ, Leya F, Pinkerton CA, et al. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med 1993; 329:221-7.
49. Adelman AG, Cohen EA, Kimball BP, et al. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery. N Engl J Med 1993;329:228-33.
50. Holmes DR Jr, Topol EJ, Califf RM, et al. A multicentre, randomised trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II Investigators. Circulation 1995;91: 1966-74.
51. Elliott JM, Berdan LG, Holmes DR, I et al. One year follow up in the coronary angioplasty versus excisional atherectomy trial (CAVEAT I). Circulation 1995;91:2158-66.
52. Teirstein PS, Massullo V, Jani S, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997;336:1697-703.
53. Cohen DJ, Breall JA, Ho KK, et al. Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decisionanalytic model. Circulation 1994;89:1859-74.
54. Cohen DJ, Krumholz HM, Sukin CA, et al. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomised clinical trial. Circulation 1995;92:2480-7.
55. Dick RJ, Popma JJ, Muller DW, et al. In hospital costs associated with new percutaneous coronary devices. Am J Cardiol 1991;68:879-85.
56. Guzman LA, Simpfendorfer C, Fix J, et al. Comparison of costs of new atherectomy devices and balloon angioplasty for coronary artery disease. Am J Cardiol 1994;74:22-5.
57. Juul-Moller S, Edvardsson N, Jahnmatz B, et al. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Lancet 1992;340:1421-5.
58. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stem implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-95.